Streamex Corp. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K covers events occurring on December 30, 2025, specifically the Company's 2025 Annual Meeting of Stockholders. Streamex Corp. is incorporated in Delaware and trades on The Nasdaq Stock Market LLC under the symbol STEX.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and shareholder voting outcomes rather than financial performance data.
Material Changes and Voting Results
At the Annual Meeting, 120,737,340 shares were represented, constituting 81.21% of the total outstanding shares entitled to vote. All six proposals submitted were approved with overwhelming support:
- Director Elections: Morgan Lekstrom (99.57% for) and Karl Henry McPhie (99.94% for) were elected as Class I Board members.
- Executive Compensation: Shareholders approved the compensation of named executive officers (99.85% for) and selected a three-year frequency for future advisory votes (99.65% for).
- Independent Auditor: The appointment of CBIZ CPAs P.C. was ratified (99.97% for).
- Incentive Plan Amendment: Shareholders approved an amendment to the 2023 Long-Term Incentive Plan, increasing the authorized share pool by 22,494,324 shares to a total of 37,230,130 shares (99.29% for).
- Adjournment: The proposal to adjourn the meeting if necessary was approved (99.12% for), though it was not required as a quorum was present.
Guidance, Outlook, and Risks
The filing contains no management commentary regarding future financial guidance, market outlook, or specific risk factors. The Board noted that future advisory votes on executive compensation will occur every three years based on the shareholder vote.
Investor Verification Checklist
- Verify the full text of the Fourth Amendment to the 2023 Long-Term Incentive Plan (Exhibit 10.1) to understand the specific terms of the increased share authorization.
- Review the Definitive Proxy Statement on Schedule 14A (filed November 20, 2025) for detailed biographies of the newly elected directors and executive compensation specifics.
- Confirm the impact of the 22.5 million share increase on potential future dilution for common stockholders.
- Check subsequent filings for the Company's actual financial results for the fiscal year ending December 31, 2025, as they are not included in this 8-K.